AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene LRRC61andC7orf29.
, go to our main page or see our latest news
Homo sapiens complex locus LRRC61andC7orf29, encoding leucine rich repeat containing 61.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 324 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 48 times), neuroblastoma cells (21), kidney (19), colon (18), neuroblastoma cot 25-normalized (15), placenta (15), eye (11), 2 pooled tumors (clear cell type) (10), lung (10), pancreas (9), adenocarcinoma cell line (8), neuroblastoma (8), neuroblastoma cot 10-normalized (8), ovary (7), renal cell adenocarcinoma (7), adrenal gland (6), neuroblastoma, cell line (6), testis (6), thalamus (6), adenocarcinoma (5), ascites (5), cord blood (5), stomach (5), thymus (5), uterus (5), whole brain (5), B cells from burkitt lymphoma (4), neuroblastoma cot 50-normalized (4), papillary serous carcinoma (4), skin (4), T cells from T cell leukemia (4), trachea (4), B cells (ramos cell line) (3), breast, tumor tissue (3), cervical carcinoma cell line (3), cervix (3), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (3), germinal center B cell (3), islets of langerhans (3), normal pigmented retinal epithelium (3), ovary, tumor tissue (3), pooled germ cell tumors (3), prostate (3), retinoblastoma (3), spleen (3), T cells (jurkat cell line) (3), b-cells (2), blood (2), breast carcinoma (2), cerebellum (2), chondrosarcoma (2), hela cells cot 25-normalized (2), hepatoblastoma (2), hippocampus (2), large cell carcinoma (2), left pelvis (2), lens (2), liver and spleen (2), lymph node (2), lymphoma, follicular mixed small and largecell (2), mammary gland (2), melanotic melanoma, high MDR (cell line) (2), nervous normal (2), ovary (pool of 3) (2), placenta cot 25-normalized (2), pooled brain, lung, testis (2), pooled pancreas and spleen (2), primary b-cells from tonsils (cell line) (2), small cell carcinoma (2), synovial membrane tissue from rheumatioidarthritis (2), uterus, tumor tissue (2), adrenal adenoma (once), amygdala (once), B cells (ramos cell line) cot 25-normalized (once), b-cell, chronic lymphotic leukemia (once), bladder (once), bone marrow (once), brain, neuroblastoma (once), breast cancer (once), carcinoid (once), carcinoma, cell line (once), caudate nucleus (once), choriocarcinoma (once), colon tumor, RER+ (once), colon, adenocarcinoma (once), colon ins (once), corpus callosum (once), early stage papillary serous carcinoma (once), embryonic stem cells, cell lines H1, H7, andh9 (once), endometrium (once), epidermis (once), epidermoid carcinoma, cell line (once), epithelioid carcinoma (once), esophageal, tumor tissue (once), fetal brain (once), heart (once), human bone marrow (once), human embryonic stem cells (once), human lung epithelial cells (once), hypothalamus (once), kidney tumor (once), leukopheresis (once), liver (once), lung, tumor tissue (once), lymph (once), lymphoma, cell line (once), mammary gland (cancer tissue) (once), medulla (once), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (once), normal prostate (once), pancreatic islet (once), parathyroid gland (once), parathyroid tumor (once), pituitary (once), pooled colon, kidney, stomach (once), primary lung cystic fibrosis epithelialcells (once), sciatic nerve (once), serous papillary carcinoma, high grade, 2pooled tumors (once), stem cell 34+/38+ (once), t-lymphocytes (once), teratocarcinoma, cell line (once), transitional cell papilloma, cell line (once), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (once).
324 cDNA clones support the 8 variants of gene LRRC61andC7orf29
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AK093915 | trachea | .a-u | 1 to 2511 | 2 to 2512 | S29P | tiling clone, available from FLJ, | | 2512/2512 (100 %) | 3 diff (99.9 %id) |
AX748363 | | .a-u | 1 to 2511 | 2 to 2512 | S29P | | | 2512/2512 (100 %) | 3 diff (99.9 %id) |
DB203518 | trachea | .a-u | 1 to 519 | 2 to 520 | | capped | | 519/519 (100 %) | 2 diff (99.7 %id) |
DB348473 | trachea | .a-u | 1974 to 2511 | 538 to 1 | | | | 538/538 (100 %) | 0 diff (100 %id) |
NM_138434.2 | | .b-u | 1 to 2871 | 1 to 2871 | exact | RefSeq, AAA | | 2871/2871 (100 %) | 0 diff (100 %id) |
DB283260 | uterus | .c-u | 1 to 543 | 2 to 544 | | tiling clone, to resequence, capped | | 543/543 (100 %) | 0 diff (100 %id) |
AL832660 | human bone marrow | .c-u | 1236 to 4171 | 1 to 2932 | A45P I46S Q47S L48W A49L ... | tiling clone, available from DKFZ, AAA | | 2932/2932 (100 %) | 14 diff (99.6 %id) |
BG326287 | Kidney, renal cell adenocarcinoma | .c-u | 1296 to 2060 | 1 to 756 | | | | 756/962 (78 %) | 27 diff (97.2 %id) |
BG323970 | Kidney, renal cell adenocarcinoma | .c-u | 1346 to 2111 | 1 to 760 | | | | 760/1070 (71 %) | 17 diff (98.5 %id) |
DN997589 | breast cancer, Mammary gland (cancer tissue) | .c-u | 1453 to 2046 | 1 to 594 | | | | 594/594 (100 %) | 5 diff (99.2 %id) |
BG682963 | brain, neuroblastoma, cell line | .c-u | 1756 to 2146 | 1 to 391 | | | | 391/391 (100 %) | 1 diff (99.8 %id) |
BM013267 | brain, neuroblastoma, cell line | .c-u | 1756 to 2146 | 1 to 394 | | | | 394/394 (100 %) | 8 diff (98.0 %id) |
BM012424 | brain, neuroblastoma, cell line | .c-u | 1756 to 2146 | 1 to 391 | | | | 391/391 (100 %) | 1 diff (99.8 %id) |
TI_59381636 | | .c-u | 1757 to 2591 | 62 to 902 | V136* | | | 841/844 (99 %) | 28 diff (96.7 %id) |
BQ070781 | brain, neuroblastoma, cell line | .c-u | 1759 to 2706 | 1 to 953 | G182X H232T R233G S234A L235F ... | | | 953/1014 (93 %) | 20 diff (98.1 %id) |
BQ898174 | brain, neuroblastoma, cell line | .c-u | 1759 to 2688 | 1 to 933 | E217X K218E K219E R220A E221R ... | | | 933/939 (99 %) | 11 diff (98.9 %id) |
BQ882023 | brain, neuroblastoma, cell line | .c-u | 1759 to 2656 | 1 to 901 | A214G Y215L W216L E217G K218E ... | | | 901/901 (100 %) | 7 diff (99.3 %id) |
BC011406 | Colon, adenocarcinoma | .c-u | 1761 to 4168 | 1 to 2408 | exact | tiling clone, available from MGC, AAA | | 2408/2408 (100 %) | 0 diff (100 %id) |
BE873251 | adenocarcinoma, colon | .c-u | 1780 to 2471 | 1 to 709 | | | | 709/868 (81 %) | 33 diff (96.2 %id) |
BG327255 | Kidney, renal cell adenocarcinoma | .c-u | 1781 to 2146 | 1 to 365 | | | | 365/365 (100 %) | 1 diff (99.8 %id) |
BM544301 | ovary (pool of 3) | .c-u | 1828 to 2745 | 25 to 946 | exact | | | 922/1065 (86 %) | 7 diff (99.4 %id) |
BX282110 | ovary (pool of 3) | .c-u | 1829 to 2315 | 1 to 487 | | | | 487/487 (100 %) | 0 diff (100 %id) |
TI_1948073280 | | .c-u | 1832 to 2019 | 102 to 294 | | | | 193/193 (100 %) | 22 diff (88.7 %id) |
TI_1948073542 | | .c-u | 1832 to 2022 | 94 to 289 | | | | 196/196 (100 %) | 22 diff (88.8 %id) |
CV025319 | mixed | .c-u | 1854 to 2533 | 1 to 679 | | | | 679/679 (100 %) | 1 diff (99.9 %id) |
TI_1948072683 | | .c-u | 1854 to 2560 | 136 to 848 | | | | 713/1332 (53 %) | 41 diff (97.0 %id) |
TI_1948072736 | | .c-u | 1854 to 2014 | 138 to 298 | | | | 161/189 (85 %) | 6 diff (96.9 %id) |
TI_1948073007 | | .c-u | 1854 to 2362 | 132 to 643 | | | | 512/1067 (47 %) | 22 diff (98.0 %id) |
TI_1948073008 | | .c-u | 1854 to 2570 | 128 to 847 | S181N G207E P224A P225T S226F ... | | | 720/1253 (57 %) | 6 diff (99.6 %id) |
TI_1948073279 | | .c-u | 1854 to 2364 | 129 to 641 | | | | 513/1063 (48 %) | 26 diff (97.6 %id) |
TI_1948073495 | | .c-u | 1854 to 2550 | 129 to 828 | | | | 700/1298 (53 %) | 54 diff (95.9 %id) |
TI_1948073541 | | .c-u | 1854 to 2458 | 132 to 741 | | | | 610/1059 (57 %) | 18 diff (98.4 %id) |
TI_1948072738 | | .c-u | 1857 to 2563 | 837 to 129 | | AAA | | 709/1088 (65 %) | 0 diff (100 %id) |
AV702775 | adrenal gland | .c-u | 2153 to 2582 | 1 to 428 | | | | 428/428 (100 %) | 6 diff (98.6 %id) |
BE259535 | brain, neuroblastoma | .c-u | 2233 to 3109 | 1 to 872 | | | | 872/941 (92 %) | 41 diff (95.7 %id) |
BE313026 | brain, neuroblastoma | .c-u | 2237 to 2850 | 1 to 611 | | | | 611/614 (99 %) | 7 diff (98.9 %id) |
TI_1948073009 | | .c-u | 2263 to 2563 | 430 to 130 | | | | 301/328 (91 %) | 0 diff (100 %id) |
BG468966 | adenocarcinoma cell line, colon | .c-u | 2290 to 2864 | 1 to 582 | | | | 582/993 (58 %) | 20 diff (98.0 %id) |
TI_1948073281 | | .c-u | 2291 to 2563 | 401 to 129 | | | | 273/300 (91 %) | 0 diff (100 %id) |
TI_1948072737 | | .c-u | 2308 to 2563 | 386 to 131 | | | | 256/284 (90 %) | 0 diff (100 %id) |
TI_1948073543 | | .c-u | 2320 to 2563 | 375 to 132 | | | | 244/271 (90 %) | 0 diff (100 %id) |
TI_59380144 | | .c-u | 2436 to 2510 | 822 to 902 | | | | 734/797 (92 %) | 49 diff (93.9 %id) |
BM050980 | eye, normal pigmented retinal epithelium | .c-u | 2699 to 3462 | 1 to 758 | | | | 758/760 (99 %) | 19 diff (97.5 %id) |
BQ948253 | eye, normal pigmented retinal epithelium | .c-u | 2702 to 3554 | 1 to 862 | | | | 862/952 (90 %) | 12 diff (98.8 %id) |
CB046213 | 2 pooled tumors (clear cell type), Kidney | .c-u | 2764 to 3409 | 1 to 646 | | | | 646/646 (100 %) | 14 diff (97.9 %id) |
BF172576 | blood | .c-u | 2827 to 3191 | 1 to 368 | | | | 368/368 (100 %) | 6 diff (98.4 %id) |
T81965 | liver and spleen | .c-u | 2838 to 3176 | 1 to 346 | | | | 346/353 (98 %) | 9 diff (97.5 %id) |
FN068750 | breast carcinoma | .c-u | 2953 to 3033 | 1 to 81 | | | | 81/82 (98 %) | 1 diff (98.8 %id) |
BM699574 | eye, lens | .c-u | 3074 to 3581 | 1 to 508 | | | | 508/508 (100 %) | 2 diff (99.7 %id) |
BG674222 | skin | .c-u | 3094 to 3947 | 1 to 856 | | | | 856/951 (90 %) | 8 diff (99.2 %id) |
BG292156 | bladder, transitional cell papilloma, cell line | .c-u | 3161 to 3838 | 1 to 675 | | | | 675/675 (100 %) | 5 diff (99.3 %id) |
TI_159716198 | | .c-u | 3262 to 4168 | 984 to 86 | | AAA | | 899/1010 (89 %) | 13 diff (98.8 %id) |
BF688918 | eye, normal pigmented retinal epithelium | .c-u | 3307 to 4131 | 841 to 25 | | | | 817/1076 (75 %) | 0 diff (100 %id) |
BM824055 | Ascites, stomach | .c-u | 3331 to 3938 | 1 to 608 | | | | 608/608 (100 %) | 1 diff (99.9 %id) |
BM722830 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c-u | 3343 to 3564 | 1 to 222 | | fully sequenced, | | 222/222 (100 %) | 1 diff (99.6 %id) |
CB852329 | Human Lung Epithelial cells, lung | .c-u | 3387 to 4168 | 799 to 19 | | AAA | | 781/781 (100 %) | 1 diff (99.9 %id) |
AA169345 | | .c-u | 3390 to 3702 | 1 to 314 | | | Submitted on the opposite strand | 314/314 (100 %) | 3 diff (99.1 %id) |
BM825453 | Ascites, stomach | .c-u | 3486 to 4029 | 1 to 544 | | | | 544/544 (100 %) | 2 diff (99.7 %id) |
BU740512 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .c-u | 3534 to 4168 | 653 to 19 | | fully sequenced, AAA | | 635/635 (100 %) | 1 diff (99.9 %id) |
BG756776 | B-cells, primary B-cells from tonsils (cell line) | .c-u | 3547 to 4174 | 1 to 629 | | | | 629/645 (97 %) | 4 diff (99.4 %id) |
BM669391 | eye, lens | .c-u | 3602 to 4168 | 585 to 19 | | AAA | | 567/578 (98 %) | 0 diff (100 %id) |
DB352631 | uterus | .c-u | 3605 to 4168 | 564 to 1 | | to resequence, | | 564/565 (99 %) | 0 diff (100 %id) |
CB047030 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3609 to 4168 | 586 to 27 | | AAA | | 560/560 (100 %) | 0 diff (100 %id) |
BG323211 | Kidney, renal cell adenocarcinoma | .c-u | 3615 to 4168 | 1 to 553 | | AAA | | 553/553 (100 %) | 2 diff (99.7 %id) |
BG422421 | Kidney, renal cell adenocarcinoma | .c-u | 3615 to 4168 | 1 to 552 | | AAA | | 552/552 (100 %) | 3 diff (99.5 %id) |
AI762857 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3617 to 4170 | 554 to 2 | | | | 553/554 (99 %) | 0 diff (100 %id) |
CB046212 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3617 to 4168 | 589 to 38 | | AAA | | 552/552 (100 %) | 1 diff (99.9 %id) |
CB046088 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3630 to 4168 | 566 to 29 | | AAA | | 538/538 (100 %) | 3 diff (99.5 %id) |
BP395635 | pancreatic islet | .c-u | 3676 to 4173 | 1 to 499 | | | Submitted on the opposite strand | 499/500 (99 %) | 5 diff (99.0 %id) |
AI949997 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3691 to 4170 | 481 to 2 | | | | 480/481 (99 %) | 0 diff (100 %id) |
AI809601 | pooled | .c-u | 3692 to 4167 | 476 to 1 | | | | 476/476 (100 %) | 1 diff (99.8 %id) |
AI681948 | carcinoid, lung | .c-u | 3693 to 4170 | 479 to 2 | | | | 478/479 (99 %) | 0 diff (100 %id) |
BU753840 | placenta | .c-u | 3694 to 4168 | 493 to 19 | | AAA | | 475/475 (100 %) | 0 diff (100 %id) |
BQ012451 | placenta | .c-u | 3715 to 4168 | 472 to 19 | | AAA | | 454/454 (100 %) | 4 diff (99.2 %id) |
AI221079 | placenta | .c-u | 3719 to 4168 | 450 to 1 | | | | 450/450 (100 %) | 0 diff (100 %id) |
AI347614 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3742 to 4170 | 430 to 2 | | | | 429/430 (99 %) | 0 diff (100 %id) |
AW167404 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .c-u | 3742 to 4173 | 433 to 2 | | | | 432/434 (99 %) | 0 diff (100 %id) |
AI023472 | liver and spleen | .c-u | 3744 to 4170 | 427 to 1 | | | | 427/427 (100 %) | 3 diff (99.3 %id) |
AI611090 | pooled germ cell tumors | .c-u | 3744 to 4169 | 426 to 1 | | | | 426/426 (100 %) | 0 diff (100 %id) |
AI347683 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3749 to 4170 | 423 to 2 | | | | 422/423 (99 %) | 0 diff (100 %id) |
AI027467 | parathyroid gland, parathyroid tumor | .c-u | 3765 to 4168 | 419 to 15 | | AAA | | 405/405 (100 %) | 1 diff (99.8 %id) |
AW591788 | lymph node, lymphoma, follicular mixed small and largecell | .c-u | 3786 to 4168 | 386 to 1 | | | | 386/386 (100 %) | 3 diff (99.3 %id) |
AI380665 | B-cell, chronic lymphotic leukemia | .c-u | 3787 to 4167 | 381 to 1 | | | | 381/381 (100 %) | 0 diff (100 %id) |
AA835735 | germinal center B cell | .c-u | 3848 to 4168 | 356 to 36 | | AAA | | 321/321 (100 %) | 0 diff (100 %id) |
AA836654 | germinal center B cell | .c-u | 3895 to 4168 | 309 to 36 | | AAA | | 274/274 (100 %) | 1 diff (99.7 %id) |
AI244028 | Kidney | .c-u | 3898 to 4170 | 273 to 1 | | | | 273/273 (100 %) | 0 diff (100 %id) |
AW193159 | adenocarcinoma, Pancreas | .c-u | 3899 to 4170 | 273 to 2 | | | | 272/273 (99 %) | 0 diff (100 %id) |
AI500112 | lymph node, lymphoma, follicular mixed small and largecell | .c-u | 3904 to 4168 | 267 to 1 | | | | 267/267 (100 %) | 2 diff (99.3 %id) |
AI918722 | pooled germ cell tumors | .c-u | 3904 to 4169 | 266 to 1 | | | | 266/266 (100 %) | 0 diff (100 %id) |
AI738693 | colon, colon tumor, RER+ | .c-u | 3908 to 4168 | 261 to 1 | | | | 261/261 (100 %) | 0 diff (100 %id) |
FN160626 | breast carcinoma | .c-u | 3924 to 4014 | 99 to 7 | | | Submitted on the opposite strand | 93/100 (93 %) | 0 diff (100 %id) |
AI702308 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .c-u | 3926 to 4168 | 255 to 13 | | AAA | | 243/243 (100 %) | 0 diff (100 %id) |
AA805365 | germinal center B cell | .c-u | 3975 to 4168 | 234 to 41 | | AAA | | 194/194 (100 %) | 0 diff (100 %id) |
AI766842 | 2 pooled tumors (clear cell type), Kidney | .c-u | 3982 to 4170 | 191 to 2 | | | | 190/191 (99 %) | 0 diff (100 %id) |
BM974674 | lung | .c-u | 4145 to 4296 | 13 to 164 | | tiling clone, | Submitted on the opposite strand | 152/166 (91 %) | 4 diff (97.6 %id) |
BF182923 | large cell carcinoma, lung | .d | 1 to 649 | 1 to 679 | R7E R8A V10G R11A A12R ... | | | 679/961 (70 %) | 66 diff (93.2 %id) |
BQ949548 | large cell carcinoma, lung | .d | 4 to 755 | 1 to 762 | Q154P I155D Y156L L157P T158D ... | tiling clone, | | 762/964 (79 %) | 18 diff (98.2 %id) |
CT003407 | T-Lymphocytes | .d | 10 to 671 | 1 to 663 | exact | tiling clone, | | 663/668 (99 %) | 2 diff (99.8 %id) |
DB239558 | trachea | .d | 24 to 562 | 2 to 540 | | capped | | 539/539 (100 %) | 0 diff (100 %id) |
DB156191 | thymus | .d | 49 to 603 | 2 to 557 | | capped | | 556/556 (100 %) | 1 diff (99.9 %id) |
DB148867 | thymus | .d | 86 to 551 | 2 to 469 | | capped | | 468/468 (100 %) | 2 diff (99.6 %id) |
BF362119 | nervous_normal | .d | 689 to 1126 | 12 to 448 | | tiling clone, | | 437/448 (97 %) | 6 diff (98.7 %id) |
CN412018 | embryonic stem cells, cell lines H1, H7, andH9 | .d | 754 to 1408 | 1 to 655 | | tiling clone, | | 655/655 (100 %) | 7 diff (99.0 %id) |
DB001467 | breast, tumor tissue | .e | 1 to 542 | 2 to 544 | R44X S45F G46R S47E S48L ... | tiling clone, capped | | 543/543 (100 %) | 2 diff (99.7 %id) |
NM_001142928.1 | | .e | 9 to 1970 | 1 to 1962 | exact | RefSeq, AAA | | 1962/1962 (100 %) | 0 diff (100 %id) |
BM918425 | pooled pancreas and spleen | .e | 13 to 1035 | 1 to 1026 | W25* | | | 1026/1026 (100 %) | 21 diff (98.0 %id) |
DB123013 | thymus | .e | 27 to 552 | 2 to 527 | | capped | | 526/526 (100 %) | 0 diff (100 %id) |
BI820548 | pooled brain, lung, testis | .e | 30 to 814 | 1 to 786 | | | | 786/786 (100 %) | 9 diff (98.9 %id) |
TI_57197490 | | .e | 30 to 814 | 71 to 856 | | | | 786/856 (91 %) | 10 diff (98.9 %id) |
DA174950 | amygdala | .e | 32 to 544 | 2 to 516 | | capped | | 515/515 (100 %) | 3 diff (99.5 %id) |
BG764257 | melanotic melanoma, high MDR (cell line), skin | .e | 34 to 826 | 1 to 794 | | | | 794/798 (99 %) | 13 diff (98.4 %id) |
BG768328 | melanotic melanoma, high MDR (cell line), skin | .e | 34 to 777 | 1 to 759 | | | | 759/952 (79 %) | 26 diff (97.3 %id) |
TI_57244882 | | .e | 73 to 713 | 30 to 666 | | | | 637/666 (95 %) | 13 diff (98.1 %id) |
BI917510 | brain | .e | 79 to 713 | 1 to 631 | | | | 631/631 (100 %) | 5 diff (99.3 %id) |
DB020859 | testis | .e | 83 to 325 | 2 to 246 | | capped | | 245/245 (100 %) | 3 diff (98.8 %id) |
DB026387 | testis | .e | 83 to 645 | 2 to 565 | | capped | | 564/564 (100 %) | 1 diff (99.9 %id) |
DB116174 | thymus | .e | 83 to 623 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DB246226 | uterus, tumor tissue | .e | 83 to 546 | 2 to 466 | | capped | | 465/465 (100 %) | 1 diff (99.8 %id) |
DA519912 | brain | .e | 86 to 645 | 2 to 561 | | capped | | 560/560 (100 %) | 1 diff (99.9 %id) |
DA686026 | | .e | 87 to 627 | 2 to 542 | | capped | | 541/541 (100 %) | 7 diff (98.8 %id) |
DB055519 | testis | .e | 87 to 659 | 2 to 579 | | capped | | 578/578 (100 %) | 9 diff (98.5 %id) |
CR625785 | HeLa cells Cot 25-normalized | .e | 89 to 1940 | 1 to 1852 | | | | 1852/1852 (100 %) | 0 diff (100 %id) |
AL555012 | placenta | .e | 89 to 909 | 1 to 815 | | fully sequenced, | | 815/815 (100 %) | 14 diff (98.3 %id) |
BM544800 | brain, hippocampus | .e | 91 to 1118 | 21 to 1063 | | | | 1043/1086 (96 %) | 32 diff (97.1 %id) |
DA071781 | cerebellum | .e | 92 to 659 | 2 to 569 | | capped | | 568/568 (100 %) | 0 diff (100 %id) |
DA646536 | mammary gland | .e | 92 to 702 | 37 to 646 | | capped | | 610/647 (94 %) | 12 diff (98.2 %id) |
AK055954 | | .e | 93 to 1964 | 1 to 1872 | | available from FLJ, | | 1872/1872 (100 %) | 11 diff (99.5 %id) |
DA202717 | brain | .e | 94 to 669 | 2 to 579 | | capped | | 578/578 (100 %) | 8 diff (98.7 %id) |
DA682820 | | .e | 94 to 842 | 2 to 767 | | capped | | 766/766 (100 %) | 28 diff (96.4 %id) |
DA702232 | | .e | 94 to 571 | 2 to 479 | | capped | | 478/478 (100 %) | 5 diff (99.0 %id) |
DB103975 | thymus | .e | 94 to 533 | 2 to 441 | | capped | | 440/453 (97 %) | 2 diff (99.6 %id) |
AL516616 | brain, neuroblastoma, neuroblastoma cells | .e | 95 to 855 | 27 to 786 | | | | 760/786 (96 %) | 20 diff (97.5 %id) |
AL519212 | brain, neuroblastoma, neuroblastoma cells | .e | 95 to 903 | 29 to 835 | | | | 807/839 (96 %) | 7 diff (99.2 %id) |
DA519981 | brain | .e | 95 to 651 | 2 to 558 | | capped | | 557/557 (100 %) | 6 diff (99.0 %id) |
TI_57220350 | | .e | 95 to 1055 | 23 to 964 | | | | 942/1011 (93 %) | 55 diff (94.6 %id) |
BU930938 | ovary, teratocarcinoma, cell line | .e | 97 to 775 | 1 to 682 | | | | 682/1002 (68 %) | 32 diff (96.9 %id) |
BI757395 | brain | .e | 101 to 1055 | 1 to 936 | | | | 936/983 (95 %) | 56 diff (94.4 %id) |
BM545428 | brain, hippocampus | .e | 101 to 907 | 1 to 820 | | | | 820/1020 (80 %) | 21 diff (98.0 %id) |
AL526909 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 102 to 1087 | 33 to 1035 | | | | 1001/1035 (96 %) | 32 diff (97.0 %id) |
BU541107 | carcinoma, cell line, Prostate | .e | 103 to 942 | 1 to 851 | | | | 851/865 (98 %) | 20 diff (97.7 %id) |
DA750857 | | .e | 104 to 669 | 2 to 567 | | capped | | 566/566 (100 %) | 5 diff (99.2 %id) |
DA687357 | | .e | 105 to 646 | 2 to 545 | | capped | | 544/544 (100 %) | 7 diff (98.8 %id) |
DA073029 | cerebellum | .e | 106 to 521 | 2 to 417 | | capped | | 416/416 (100 %) | 1 diff (99.8 %id) |
DA640793 | Liver | .e | 111 to 651 | 2 to 542 | | capped | | 541/541 (100 %) | 0 diff (100 %id) |
DB034806 | testis | .e | 111 to 685 | 2 to 577 | | capped | | 576/576 (100 %) | 2 diff (99.7 %id) |
AL526492 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 112 to 1068 | 1 to 952 | | | | 952/952 (100 %) | 13 diff (98.7 %id) |
DA690975 | | .e | 118 to 685 | 2 to 569 | | capped | | 568/568 (100 %) | 5 diff (99.2 %id) |
DA696160 | | .e | 120 to 572 | 2 to 455 | | capped | | 454/455 (99 %) | 8 diff (98.3 %id) |
DA842998 | placenta | .e | 120 to 713 | 2 to 598 | | capped | | 597/597 (100 %) | 4 diff (99.4 %id) |
DA909603 | | .e | 120 to 691 | 2 to 575 | | capped | | 574/574 (100 %) | 2 diff (99.7 %id) |
DA911172 | | .e | 120 to 677 | 2 to 559 | | capped | | 558/558 (100 %) | 5 diff (99.2 %id) |
DB057577 | testis | .e | 120 to 656 | 2 to 538 | | capped | | 537/537 (100 %) | 0 diff (100 %id) |
AL558785 | T cells from T cell leukemia | .e | 121 to 976 | 1 to 854 | | | | 854/854 (100 %) | 6 diff (99.3 %id) |
BE797439 | lung, small cell carcinoma | .e | 121 to 963 | 1 to 835 | | | | 835/1141 (73 %) | 19 diff (98.4 %id) |
TI_57244626 | | .e | 121 to 903 | 35 to 815 | | | | 781/815 (95 %) | 9 diff (98.9 %id) |
BI917336 | brain | .e | 122 to 903 | 1 to 780 | | | | 780/780 (100 %) | 4 diff (99.5 %id) |
CR596920 | Neuroblastoma Cot 25-normalized | .e | 123 to 1951 | 1 to 1829 | | | | 1829/1829 (100 %) | 0 diff (100 %id) |
AL526590 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 123 to 1043 | 1 to 909 | | fully sequenced, | | 909/909 (100 %) | 6 diff (99.4 %id) |
BI914639 | brain | .e | 123 to 820 | 1 to 708 | | | | 708/711 (99 %) | 13 diff (98.2 %id) |
TI_57240753 | | .e | 123 to 820 | 28 to 735 | | | | 708/738 (95 %) | 15 diff (98.0 %id) |
DR002132 | fetal brain | .e | 124 to 668 | 1 to 543 | | | | 543/543 (100 %) | 7 diff (98.8 %id) |
DA701825 | | .e | 125 to 644 | 2 to 522 | | capped | | 521/521 (100 %) | 9 diff (98.3 %id) |
CR604731 | Neuroblastoma Cot 25-normalized | .e | 126 to 1935 | 1 to 1810 | | | | 1810/1810 (100 %) | 0 diff (100 %id) |
CR619181 | Neuroblastoma Cot 25-normalized | .e | 126 to 1952 | 1 to 1827 | | tiling clone, | | 1827/1827 (100 %) | 0 diff (100 %id) |
AL525735 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 126 to 1047 | 1 to 913 | | fully sequenced, | | 913/913 (100 %) | 13 diff (98.6 %id) |
AL526401 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 126 to 1016 | 1 to 887 | | fully sequenced, | | 887/887 (100 %) | 13 diff (98.6 %id) |
DA747344 | | .e | 127 to 685 | 2 to 560 | | capped | | 559/559 (100 %) | 6 diff (99.0 %id) |
CR604499 | B cells (Ramos cell line) Cot 25-normalized | .e | 133 to 1918 | 1 to 1786 | | | | 1786/1786 (100 %) | 0 diff (100 %id) |
AL583122 | B cells from Burkitt lymphoma | .e | 133 to 941 | 1 to 809 | | fully sequenced, | | 809/809 (100 %) | 11 diff (98.7 %id) |
CR606039 | B cells (Ramos cell line) | .e | 136 to 1920 | 1 to 1785 | | | | 1785/1785 (100 %) | 0 diff (100 %id) |
AL522773 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 136 to 1022 | 1 to 885 | | | | 885/885 (100 %) | 12 diff (98.7 %id) |
AL559743 | B cells (Ramos cell line), B cells from Burkitt lymphoma | .e | 136 to 1063 | 1 to 921 | | fully sequenced, | | 921/921 (100 %) | 12 diff (98.7 %id) |
BI820905 | pooled brain, lung, testis | .e | 137 to 959 | 1 to 825 | | | | 825/826 (99 %) | 9 diff (99.0 %id) |
TI_57197091 | | .e | 137 to 959 | 72 to 896 | | | | 825/897 (91 %) | 12 diff (98.7 %id) |
BE872386 | adenocarcinoma, colon | .e | 138 to 226 | 1 to 89 | | | | 89/89 (100 %) | 0 diff (100 %id) |
BX355204 | Neuroblastoma Cot 50-normalized | .e | 140 to 933 | 1 to 794 | | | | 794/794 (100 %) | 8 diff (99.0 %id) |
AL546135 | placenta, Placenta Cot 25-normalized | .e | 143 to 927 | 1 to 795 | | | | 795/795 (100 %) | 67 diff (91.6 %id) |
DA731538 | | .e | 143 to 962 | 2 to 825 | | capped | | 824/827 (99 %) | 36 diff (95.7 %id) |
BG774135 | choriocarcinoma, placenta | .e | 145 to 970 | 1 to 826 | | | | 826/827 (99 %) | 6 diff (99.3 %id) |
DA515701 | brain | .e | 157 to 619 | 2 to 468 | | capped | | 467/467 (100 %) | 8 diff (98.3 %id) |
DA728762 | | .e | 158 to 988 | 2 to 819 | | capped | | 818/818 (100 %) | 23 diff (97.2 %id) |
DA753101 | | .e | 158 to 669 | 2 to 514 | | capped | | 513/513 (100 %) | 5 diff (99.1 %id) |
DA760717 | | .e | 158 to 731 | 2 to 576 | | capped | | 575/575 (100 %) | 5 diff (99.2 %id) |
DB191085 | lung, tumor tissue | .e | 158 to 730 | 2 to 574 | | capped | | 573/573 (100 %) | 0 diff (100 %id) |
BG395045 | eye, retinoblastoma | .e | 159 to 838 | 1 to 679 | | | | 679/679 (100 %) | 8 diff (98.9 %id) |
DA691926 | | .e | 159 to 719 | 2 to 562 | | capped | | 561/561 (100 %) | 5 diff (99.2 %id) |
BI457640 | brain, hypothalamus | .e | 166 to 914 | 1 to 748 | | | | 748/748 (100 %) | 9 diff (98.8 %id) |
DN601899 | human embryonic stem cells | .e | 166 to 748 | 1 to 583 | | | | 583/583 (100 %) | 0 diff (100 %id) |
TI_57152175 | | .e | 166 to 1009 | 28 to 871 | | | | 844/871 (96 %) | 32 diff (96.4 %id) |
BI763529 | pooled colon, kidney, stomach | .e | 173 to 1009 | 1 to 837 | | | | 837/837 (100 %) | 25 diff (97.1 %id) |
BX331819 | Neuroblastoma Cot 25-normalized | .e | 174 to 1192 | 1 to 1028 | | | | 984/1035 (95 %) | 42 diff (96.0 %id) |
BE254277 | eye, retinoblastoma | .e | 179 to 791 | 1 to 613 | | | | 613/613 (100 %) | 6 diff (99.1 %id) |
DA037725 | | .e | 180 to 689 | 2 to 511 | | capped | | 510/510 (100 %) | 3 diff (99.5 %id) |
DA684005 | | .e | 180 to 685 | 2 to 507 | | capped | | 506/506 (100 %) | 4 diff (99.3 %id) |
CR608616 | Neuroblastoma Cot 10-normalized | .e | 181 to 1934 | 1 to 1754 | | | | 1754/1754 (100 %) | 0 diff (100 %id) |
AL522485 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 181 to 1054 | 1 to 871 | | fully sequenced, | | 871/871 (100 %) | 23 diff (97.4 %id) |
TI_57166446 | | .e | 181 to 1009 | 27 to 859 | | | | 833/861 (96 %) | 30 diff (96.6 %id) |
BI833378 | pooled pancreas and spleen | .e | 184 to 1009 | 1 to 830 | | | | 830/832 (99 %) | 31 diff (96.3 %id) |
CR613542 | T cells (Jurkat cell line) | .e | 190 to 1941 | 1 to 1752 | | | | 1752/1752 (100 %) | 0 diff (100 %id) |
AL557126 | T cells (Jurkat cell line), T cells from T cell leukemia | .e | 190 to 1113 | 1 to 914 | | fully sequenced, | | 914/914 (100 %) | 13 diff (98.6 %id) |
TI_57172580 | | .e | 210 to 1022 | 33 to 851 | | | | 819/874 (93 %) | 27 diff (97.0 %id) |
BJ993544 | hepatoblastoma | .e | 214 to 703 | 1 to 490 | | | | 490/490 (100 %) | 2 diff (99.6 %id) |
BI828768 | brain, medulla | .e | 215 to 1022 | 1 to 814 | | | | 814/837 (97 %) | 24 diff (97.2 %id) |
BQ340886 | nervous_normal | .e | 225 to 338 | 1 to 114 | | | | 114/114 (100 %) | 4 diff (96.5 %id) |
CR622405 | placenta | .e | 243 to 1952 | 1 to 1710 | | | | 1710/1710 (100 %) | 0 diff (100 %id) |
AL540950 | placenta | .e | 243 to 1109 | 1 to 856 | | fully sequenced, | | 856/856 (100 %) | 8 diff (99.1 %id) |
BE245022 | leukopheresis | .e | 253 to 743 | 1 to 492 | | | | 492/492 (100 %) | 9 diff (98.2 %id) |
BI199065 | brain, neuroblastoma | .e | 263 to 1032 | 1 to 774 | | | | 774/775 (99 %) | 31 diff (96.0 %id) |
BP321992 | Pancreas | .e | 267 to 850 | 1 to 583 | | | | 583/583 (100 %) | 1 diff (99.9 %id) |
BG747370 | adenocarcinoma cell line, colon | .e | 276 to 1043 | 1 to 768 | | | | 768/772 (99 %) | 4 diff (99.5 %id) |
BG747293 | adenocarcinoma cell line, colon | .e | 276 to 954 | 1 to 696 | | | | 654/699 (93 %) | 16 diff (97.8 %id) |
BG747286 | adenocarcinoma cell line, colon | .e | 276 to 814 | 1 to 540 | | | | 540/540 (100 %) | 1 diff (99.9 %id) |
BG821169 | adenocarcinoma cell line, colon | .e | 276 to 1167 | 1 to 893 | | | | 893/901 (99 %) | 26 diff (97.2 %id) |
BE292749 | adenocarcinoma cell line, colon | .e | 296 to 938 | 1 to 645 | | | | 645/646 (99 %) | 4 diff (99.4 %id) |
BE304834 | adenocarcinoma cell line, colon | .e | 296 to 899 | 1 to 605 | | | | 605/678 (89 %) | 15 diff (97.8 %id) |
BE293329 | adenocarcinoma cell line, colon | .e | 296 to 941 | 1 to 642 | | | | 642/715 (89 %) | 13 diff (98.2 %id) |
BE792905 | lung, small cell carcinoma | .e | 298 to 1078 | 1 to 782 | | | | 782/803 (97 %) | 33 diff (95.9 %id) |
BI917893 | brain | .e | 300 to 877 | 237 to 825 | | | | 589/826 (71 %) | 27 diff (96.8 %id) |
TI_57242487 | | .e | 300 to 877 | 276 to 864 | | | | 589/865 (68 %) | 27 diff (96.9 %id) |
BG324292 | Kidney, renal cell adenocarcinoma | .e | 302 to 1165 | 1 to 858 | | | | 858/858 (100 %) | 36 diff (95.9 %id) |
BM795052 | Ascites, stomach | .e | 317 to 965 | 1 to 649 | | | | 649/649 (100 %) | 2 diff (99.7 %id) |
DA999032 | breast, tumor tissue | .e | 321 to 881 | 2 to 562 | | capped | | 561/561 (100 %) | 0 diff (100 %id) |
AL577619 | placenta | .e | 890 to 1940 | 1032 to 1 | | fully sequenced, | | 1032/1032 (100 %) | 29 diff (97.2 %id) |
AL583121 | B cells from Burkitt lymphoma | .e | 911 to 1918 | 1003 to 1 | | fully sequenced, | | 1003/1003 (100 %) | 11 diff (99.0 %id) |
AL526589 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 986 to 1952 | 964 to 1 | | fully sequenced, | | 964/964 (100 %) | 7 diff (99.3 %id) |
AL526534 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 1013 to 1951 | 927 to 1 | | fully sequenced, | | 927/927 (100 %) | 16 diff (98.3 %id) |
AL562555 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 1017 to 1935 | 914 to 1 | | fully sequenced, | | 914/914 (100 %) | 18 diff (98.1 %id) |
AL522484 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 1024 to 1893 | 908 to 42 | | fully sequenced, | | 867/908 (95 %) | 38 diff (95.9 %id) |
AL559742 | B cells (Ramos cell line), B cells from Burkitt lymphoma | .e | 1033 to 1920 | 882 to 1 | | fully sequenced, | | 882/882 (100 %) | 9 diff (99.0 %id) |
AL580527 | T cells from T cell leukemia | .e | 1033 to 1930 | 901 to 1 | | | | 901/901 (100 %) | 18 diff (98.1 %id) |
AL522772 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 1047 to 1904 | 888 to 35 | | | | 854/929 (91 %) | 0 diff (100 %id) |
AL568667 | placenta | .e | 1079 to 1909 | 867 to 46 | | fully sequenced, | | 822/867 (94 %) | 17 diff (98.1 %id) |
AL557125 | T cells (Jurkat cell line), T cells from T cell leukemia | .e | 1083 to 1941 | 852 to 1 | | fully sequenced, | | 852/852 (100 %) | 13 diff (98.5 %id) |
AL519211 | brain, neuroblastoma, neuroblastoma cells | .e | 1084 to 1903 | 864 to 45 | | | | 820/864 (94 %) | 0 diff (100 %id) |
AL571604 | placenta, Placenta Cot 25-normalized | .e | 1105 to 1933 | 830 to 7 | | | | 824/830 (99 %) | 55 diff (93.4 %id) |
AL516615 | brain, neuroblastoma, neuroblastoma cells | .e | 1123 to 1946 | 822 to 1 | | | | 822/822 (100 %) | 23 diff (97.3 %id) |
AL562811 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 1183 to 1929 | 752 to 10 | | | | 743/1035 (71 %) | 0 diff (100 %id) |
BJ993545 | hepatoblastoma | .e | 1416 to 1894 | 479 to 1 | | | | 479/480 (99 %) | 31 diff (93.6 %id) |
DB353803 | | .e | 1459 to 1970 | 509 to 1 | | | | 509/509 (100 %) | 13 diff (97.5 %id) |
DB322631 | | .e | 1490 to 1964 | 476 to 1 | | | | 476/476 (100 %) | 11 diff (97.7 %id) |
DB361226 | mammary gland | .e | 1534 to 1970 | 438 to 1 | | tiling clone, | | 438/489 (89 %) | 2 diff (99.6 %id) |
BX392093 | Neuroblastoma Cot 25-normalized | .e | 1603 to 1958 | 356 to 1 | | | | 356/356 (100 %) | 2 diff (99.5 %id) |
AK098061 | ovary, tumor tissue | .f | 1 to 1967 | 2 to 1968 | exact | tiling clone, available from FLJ, | | 1968/1968 (100 %) | 4 diff (99.8 %id) |
DB192405 | ovary, tumor tissue | .f | 1 to 553 | 2 to 554 | exact | capped | | 553/553 (100 %) | 0 diff (100 %id) |
DB246218 | uterus, tumor tissue | .f | 19 to 590 | 2 to 573 | exact | capped | | 572/572 (100 %) | 0 diff (100 %id) |
BI334449 | cervical carcinoma cell line, cervix | .f | 355 to 967 | 1 to 613 | | | | 613/613 (100 %) | 7 diff (98.9 %id) |
BG758667 | B-cells, primary B-cells from tonsils (cell line) | .f | 365 to 1038 | 1 to 674 | | | | 674/674 (100 %) | 1 diff (99.9 %id) |
BQ943022 | epidermoid carcinoma, cell line, lung | .f | 375 to 1246 | 1 to 880 | | | | 880/904 (97 %) | 19 diff (97.9 %id) |
AW969255 | | .f | 390 to 751 | 35 to 396 | | | | 362/396 (91 %) | 6 diff (98.5 %id) |
AI821209 | colon | .f | 390 to 877 | 1 to 488 | | | | 488/497 (98 %) | 1 diff (99.8 %id) |
AI821213 | colon | .f | 390 to 887 | 1 to 498 | | | | 498/498 (100 %) | 0 diff (100 %id) |
R36051 | whole brain | .f | 439 to 764 | 1 to 327 | | | | 327/439 (74 %) | 3 diff (99.4 %id) |
CR602087 | HeLa cells Cot 25-normalized | .f | 443 to 1937 | 1 to 1495 | | tiling clone, | | 1495/1495 (100 %) | 0 diff (100 %id) |
AL555865 | placenta | .f | 443 to 1180 | 1 to 736 | | fully sequenced, | | 736/736 (100 %) | 4 diff (99.5 %id) |
BP325070 | Pancreas | .f | 453 to 1034 | 1 to 582 | | | | 582/582 (100 %) | 5 diff (99.2 %id) |
AI807218 | pooled | .f | 494 to 967 | 514 to 41 | | | | 474/514 (92 %) | 0 diff (100 %id) |
AK025869 | | .f | 504 to 1967 | 1 to 1464 | | tiling clone, available from FLJ, AAA | | 1464/1464 (100 %) | 1 diff (100.0 %id) |
AL578256 | placenta | .f | 1150 to 1921 | 781 to 15 | | fully sequenced, | | 767/781 (98 %) | 8 diff (99.0 %id) |
DB347757 | ovary, tumor tissue | .f | 1430 to 1967 | 539 to 1 | | | | 539/539 (100 %) | 6 diff (98.9 %id) |
R49133 | whole brain | .f | 1544 to 1961 | 438 to 12 | | AAA | | 427/427 (100 %) | 15 diff (96.5 %id) |
DA375460 | thalamus | .g | 1 to 527 | 2 to 528 | | tiling clone, capped | | 527/527 (100 %) | 2 diff (99.7 %id) |
DA014909 | adrenal gland | .g | 58 to 569 | 2 to 513 | | tiling clone, capped | | 512/512 (100 %) | 1 diff (99.9 %id) |
NM_023942.2 | | .g | 497 to 2288 | 1 to 1792 | exact | RefSeq, AAA | | 1792/1792 (100 %) | 0 diff (100 %id) |
CR608476 | Neuroblastoma Cot 50-normalized | .g | 553 to 2236 | 1 to 1684 | | tiling clone, | | 1684/1684 (100 %) | 0 diff (100 %id) |
AL529144 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .g | 583 to 1405 | 27 to 845 | | fully sequenced, | | 819/845 (96 %) | 13 diff (98.5 %id) |
DA430182 | colon | .g | 608 to 1170 | 2 to 565 | | capped | | 564/564 (100 %) | 6 diff (99.0 %id) |
CR624936 | Neuroblastoma Cot 10-normalized | .g | 662 to 2269 | 1 to 1608 | | | | 1608/1608 (100 %) | 0 diff (100 %id) |
AL519713 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .g | 662 to 1467 | 1 to 804 | | fully sequenced, | | 804/804 (100 %) | 7 diff (99.2 %id) |
BC001354 | Brain, neuroblastoma | .g | 806 to 2282 | 9 to 1485 | | tiling clone, available from MGC, AAA | | 1477/1477 (100 %) | 0 diff (100 %id) |
BE313593 | brain, neuroblastoma | .g | 825 to 1480 | 1 to 655 | | | | 655/725 (90 %) | 21 diff (97.2 %id) |
AL563351 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .g | 1375 to 2236 | 860 to 1 | | fully sequenced, | | 860/860 (100 %) | 14 diff (98.4 %id) |
AL561812 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .g | 1437 to 2269 | 831 to 1 | | fully sequenced, | | 831/831 (100 %) | 5 diff (99.4 %id) |
AA078373 | placenta | .h | 1 to 233 | 233 to 1 | | tiling clone, | | 233/233 (100 %) | 2 diff (99.2 %id) |
DA380086 | thalamus | .h | 153 to 698 | 2 to 547 | | capped | | 546/546 (100 %) | 1 diff (99.9 %id) |
DA276405 | corpus callosum | .h | 163 to 689 | 2 to 528 | | capped | | 527/527 (100 %) | 0 diff (100 %id) |
DA977677 | synovial membrane tissue from rheumatioidarthritis | .h | 170 to 731 | 2 to 563 | | capped | | 562/562 (100 %) | 6 diff (99.0 %id) |
DB002865 | breast, tumor tissue | .h | 172 to 689 | 2 to 519 | | capped | | 518/518 (100 %) | 0 diff (100 %id) |
DA014521 | adrenal gland | .h | 173 to 744 | 2 to 573 | | capped | | 572/572 (100 %) | 2 diff (99.7 %id) |
DA371056 | thalamus | .h | 173 to 739 | 2 to 568 | | capped | | 567/567 (100 %) | 2 diff (99.7 %id) |
DA381184 | thalamus | .h | 173 to 706 | 2 to 535 | | capped | | 534/534 (100 %) | 1 diff (99.9 %id) |
DA670245 | | .h | 173 to 722 | 2 to 551 | | tiling clone, capped | | 550/551 (99 %) | 2 diff (99.7 %id) |
DA936889 | Spleen | .h | 173 to 759 | 2 to 588 | | capped | | 587/587 (100 %) | 1 diff (99.9 %id) |
DA014069 | adrenal gland | .h | 175 to 666 | 2 to 493 | | capped | | 492/492 (100 %) | 0 diff (100 %id) |
DA378199 | thalamus | .h | 175 to 666 | 2 to 494 | | capped | | 493/493 (100 %) | 1 diff (99.8 %id) |
DA980133 | synovial membrane tissue from rheumatioidarthritis | .h | 175 to 747 | 2 to 574 | | capped | | 573/573 (100 %) | 1 diff (99.9 %id) |
DB014660 | esophageal, tumor tissue | .h | 190 to 765 | 2 to 575 | | capped | | 574/574 (100 %) | 2 diff (99.7 %id) |
DA949948 | Spleen | .h | 234 to 788 | 2 to 556 | | tiling clone, capped | | 555/555 (100 %) | 0 diff (100 %id) |
DA009892 | adrenal gland | .h | 247 to 804 | 2 to 559 | | capped | | 558/558 (100 %) | 1 diff (99.9 %id) |
DB037159 | testis | .h | 269 to 834 | 2 to 568 | | capped | | 567/567 (100 %) | 2 diff (99.7 %id) |
DA266216 | caudate nucleus | .h | 504 to 1053 | 2 to 551 | | tiling clone, capped | | 550/550 (100 %) | 1 diff (99.9 %id) |
CD107920 | brain, Pituitary | .h | 904 to 1745 | 1 to 851 | | | | 851/859 (99 %) | 14 diff (98.4 %id) |
AA295306 | Pancreas | .h | 908 to 1163 | 11 to 266 | | | | 256/266 (96 %) | 6 diff (97.8 %id) |
AI807212 | pooled | .h | 928 to 1314 | 387 to 1 | | | | 387/387 (100 %) | 8 diff (98.0 %id) |
BF801176 | colon_ins | .h | 961 to 1556 | 32 to 625 | | | | 594/626 (94 %) | 5 diff (99.3 %id) |
AA337557 | endometrium | .h | 978 to 1229 | 1 to 252 | | | | 252/252 (100 %) | 0 diff (100 %id) |
AA338692 | brain | .h | 1026 to 1130 | 1 to 105 | | | | 105/105 (100 %) | 0 diff (100 %id) |
TI_1948073722 | | .h | 1039 to 1816 | 129 to 908 | | tiling clone, | | 780/1163 (67 %) | 6 diff (99.5 %id) |
TI_1948073893 | | .h | 1039 to 1815 | 140 to 919 | | | | 780/1156 (67 %) | 8 diff (99.4 %id) |
TI_1948074075 | | .h | 1039 to 1807 | 140 to 910 | | fully sequenced, | | 771/910 (84 %) | 6 diff (99.4 %id) |
TI_1948074246 | | .h | 1039 to 1700 | 137 to 806 | | | | 670/1271 (52 %) | 17 diff (98.7 %id) |
CV029262 | mixed | .h | 1040 to 1535 | 1 to 496 | | | | 496/496 (100 %) | 4 diff (99.2 %id) |
AA326999 | lung | .h | 1042 to 1319 | 1 to 277 | | | | 277/277 (100 %) | 1 diff (99.7 %id) |
R51431 | whole brain | .h | 1090 to 1506 | 1 to 422 | | | | 422/463 (91 %) | 10 diff (97.9 %id) |
BX282200 | cervical carcinoma cell line, cervix | .h | 1187 to 1662 | 1 to 476 | | | | 476/476 (100 %) | 2 diff (99.6 %id) |
BI259806 | cervical carcinoma cell line, cervix | .h | 1187 to 1979 | 1 to 790 | | | | 790/792 (99 %) | 12 diff (98.5 %id) |
BE250908 | eye, retinoblastoma | .h | 1210 to 1695 | 1 to 488 | | | | 488/488 (100 %) | 2 diff (99.6 %id) |
BM792256 | Ascites, stomach | .h | 1250 to 1481 | 1 to 232 | | | | 232/232 (100 %) | 20 diff (91.4 %id) |
BX394714 | Neuroblastoma Cot 25-normalized | .h | 1275 to 2267 | 993 to 1 | | | | 993/1078 (92 %) | 28 diff (97.5 %id) |
BE905372 | epithelioid carcinoma, Pancreas | .h | 1308 to 2032 | 1 to 722 | | | | 722/722 (100 %) | 9 diff (98.8 %id) |
BM455442 | lymph, lymphoma, cell line | .h | 1340 to 2171 | 31 to 868 | | | | 838/1124 (74 %) | 10 diff (99.2 %id) |
BM126396 | Islets of Langerhans, Pancreas | .h | 1362 to 1850 | 1 to 490 | | | | 490/490 (100 %) | 2 diff (99.6 %id) |
TI_1948074076 | | .h | 1458 to 1824 | 503 to 127 | | fully sequenced, | | 377/503 (74 %) | 5 diff (99.1 %id) |
AI732196 | colon | .h | 1496 to 1895 | 476 to 77 | | AAA | | 400/458 (87 %) | 14 diff (97.0 %id) |
TI_149311980 | | .h | 1500 to 2327 | 907 to 89 | | tiling clone, AAA | | 819/963 (85 %) | 16 diff (98.4 %id) |
BE613162 | adenocarcinoma, ovary | .h | 1523 to 2270 | 746 to 1 | | | | 746/746 (100 %) | 14 diff (98.2 %id) |
BM796446 | Ascites, stomach | .h | 1537 to 1978 | 1 to 442 | | | | 442/442 (100 %) | 1 diff (99.8 %id) |
BQ947470 | sciatic nerve | .h | 1554 to 2327 | 1 to 774 | | | | 774/925 (83 %) | 4 diff (99.6 %id) |
AA077645 | | .h | 1567 to 1855 | 1 to 289 | | | | 289/289 (100 %) | 2 diff (99.4 %id) |
AI732193 | colon | .h | 1572 to 1895 | 400 to 77 | | AAA | | 324/382 (84 %) | 14 diff (96.4 %id) |
AA468776 | colon | .h | 1582 to 1895 | 388 to 77 | | AAA | | 312/370 (84 %) | 0 diff (100 %id) |
AA468630 | colon | .h | 1589 to 1895 | 381 to 77 | | AAA | | 305/363 (84 %) | 0 diff (100 %id) |
BM977633 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .h | 1668 to 2327 | 678 to 19 | | AAA | | 660/660 (100 %) | 1 diff (99.9 %id) |
AF161413 | blood | .h | 1736 to 2333 | 86 to 683 | | AAA | | 598/683 (87 %) | 6 diff (99.2 %id) |
BG423593 | Kidney, renal cell adenocarcinoma | .h | 1755 to 2272 | 1 to 541 | | | | 541/1032 (52 %) | 26 diff (97.5 %id) |
BQ006180 | Chondrosarcoma, Left Pelvis | .h | 1801 to 2333 | 551 to 19 | | AAA | | 533/533 (100 %) | 4 diff (99.3 %id) |
DB332895 | Spleen | .h | 1801 to 2333 | 533 to 1 | | | | 533/533 (100 %) | 2 diff (99.7 %id) |
BX093316 | whole brain | .h | 1821 to 2327 | 522 to 15 | | AAA | | 508/508 (100 %) | 1 diff (99.9 %id) |
R51319 | whole brain | .h | 1872 to 2333 | 477 to 13 | | AAA | | 465/465 (100 %) | 7 diff (98.5 %id) |
H41438 | brain | .h | 1889 to 2326 | 455 to 15 | | | | 441/460 (95 %) | 0 diff (100 %id) |
BM126106 | Islets of Langerhans, Pancreas | .h | 1896 to 2333 | 449 to 12 | | AAA | | 438/438 (100 %) | 3 diff (99.4 %id) |
BM987618 | mixed | .h | 1904 to 2327 | 442 to 19 | | AAA | | 424/424 (100 %) | 7 diff (98.4 %id) |
AA600981 | adrenal adenoma, adrenal gland | .h | 1940 to 2294 | 355 to 1 | | | | 355/355 (100 %) | 1 diff (99.8 %id) |
AW444958 | | .h | 1956 to 2333 | 395 to 18 | | AAA | | 378/387 (97 %) | 0 diff (100 %id) |
CB046334 | 2 pooled tumors (clear cell type), Kidney | .h | 1968 to 2333 | 13 to 378 | | AAA | | 366/378 (96 %) | 6 diff (98.5 %id) |
AI589436 | adenocarcinoma, Pancreas | .h | 1980 to 2334 | 361 to 7 | | | | 355/361 (98 %) | 0 diff (100 %id) |
AW512442 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .h | 1982 to 2334 | 356 to 4 | | tiling clone, | | 353/356 (99 %) | 0 diff (100 %id) |
BQ006918 | Chondrosarcoma, Left Pelvis | .h | 1985 to 2333 | 367 to 19 | | AAA | | 349/357 (97 %) | 1 diff (99.8 %id) |
BQ187134 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h | 1998 to 2333 | 1 to 336 | | AAA | | 336/336 (100 %) | 1 diff (99.8 %id) |
AI349626 | bone marrow, stem cell 34+/38+ | .h | 2000 to 2334 | 9 to 343 | | AAA | Submitted on the opposite strand | 335/343 (97 %) | 6 diff (98.3 %id) |
AI344897 | early stage papillary serous carcinoma, ovary | .h | 2000 to 2330 | 9 to 339 | | | Submitted on the opposite strand | 331/371 (89 %) | 2 diff (99.5 %id) |
AW271014 | ovary, papillary serous carcinoma | .h | 2000 to 2271 | 9 to 287 | | | Submitted on the opposite strand | 279/288 (96 %) | 13 diff (95.5 %id) |
AW271143 | ovary, papillary serous carcinoma | .h | 2000 to 2317 | 9 to 325 | | | Submitted on the opposite strand | 317/325 (97 %) | 6 diff (98.2 %id) |
AV739286 | cord Blood | .h | 2001 to 2325 | 33 to 354 | | AAA | | 322/354 (90 %) | 6 diff (98.4 %id) |
AV742952 | cord Blood | .h | 2001 to 2326 | 26 to 350 | | AAA | | 325/350 (92 %) | 6 diff (98.3 %id) |
AI144038 | ovary, papillary serous carcinoma | .h | 2001 to 2333 | 20 to 353 | | AAA | Submitted on the opposite strand | 334/353 (94 %) | 6 diff (98.4 %id) |
BF718518 | epidermis, skin | .h | 2010 to 2332 | 324 to 2 | | | | 323/324 (99 %) | 0 diff (100 %id) |
AI140382 | heart | .h | 2011 to 2334 | 332 to 9 | | | | 324/332 (97 %) | 0 diff (100 %id) |
AA582540 | Kidney, kidney tumor | .h | 2013 to 2327 | 364 to 50 | | AAA | | 315/315 (100 %) | 0 diff (100 %id) |
AA976044 | pooled germ cell tumors | .h | 2035 to 2334 | 300 to 1 | | | | 300/300 (100 %) | 1 diff (99.7 %id) |
H51527 | brain | .h | 2045 to 2326 | 289 to 7 | | | | 283/294 (96 %) | 0 diff (100 %id) |
AI865638 | normal prostate, Prostate | .h | 2045 to 2334 | 292 to 3 | | | | 290/292 (99 %) | 0 diff (100 %id) |
AV739754 | cord Blood | .h | 2125 to 2326 | 40 to 239 | | AAA | | 200/239 (83 %) | 6 diff (97.5 %id) |
AV741232 | cord Blood | .h | 2125 to 2326 | 40 to 239 | | AAA | | 200/239 (83 %) | 6 diff (97.5 %id) |
AV744361 | cord Blood | .h | 2125 to 2326 | 39 to 238 | | AAA | | 200/238 (84 %) | 6 diff (97.5 %id) |
AI053787 | ovary, papillary serous carcinoma | .h | 2142 to 2333 | 211 to 20 | | AAA | | 192/192 (100 %) | 1 diff (99.5 %id) |
AI800018 | Prostate | .h | 2177 to 2334 | 160 to 3 | | | | 158/160 (98 %) | 0 diff (100 %id) |
BM128023 | Islets of Langerhans, Pancreas | .h | 2218 to 2322 | 1 to 105 | | | | 105/105 (100 %) | 1 diff (99.1 %id) |
AK127403 | thalamus | Gene LRRC61andC7orf29, variant not shown | | | | available from FLJ, | This clone was ignored | | |
? | Gene Summary |
Gene on genome |
mRNA:.a-u, .b-u, .c-u, .d, .e, .f, .g, .h |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes C |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !